-
公开(公告)号:US20120208177A1
公开(公告)日:2012-08-16
申请号:US13391563
申请日:2010-08-25
申请人: Susan Baigent , Venugopal Nair , Hervé Le Galludec
发明人: Susan Baigent , Venugopal Nair , Hervé Le Galludec
IPC分类号: C12Q1/70
CPC分类号: C12Q1/705 , C12Q2600/156
摘要: A method for the quantification of a vaccine strain and/or a virulent strain of Wlarek's Disease Virus Serotype-1 (MDV-1) in a sample from a bird, comprising the steps of: (i) providing a biological sample from the bird and optionally isolating nucleic acid from the biological sample; (ii) subjecting the biological sample of (i) to real-time quantitative PCR (qPCR) comprising: (a) amplification of a region of the pp3B gene within the nucleic acid sample of (i), said region containing a consistent single nucleotide polymorphism (SNP) difference between vaccine and virulent strains of MDV-1; and (b) contacting the amplified nucleic acid of (a) with a detectable nucleic acid probe specific for the SNP of the vaccine strain of MDV-1 and/or a detectable nucleic aα′d probe specific for the SNP of the virulent strain of MDV-1; and (iii) Measuring changes in the detectable signal produced by the probe of (ii). Methods are also provided for the absolute quantification of vaccine and virulent viruses.
摘要翻译: 一种用于定量来自鸟的样品中的Wlarek's病毒血清型-1(MDV-1)的疫苗株和/或毒力株的方法,包括以下步骤:(i)从鸟提供生物样品, 任选地从生物样品中分离核酸; (ii)对(i)生物样品进行实时定量PCR(qPCR),包括:(a)在(i)的核酸样品中扩增pp3B基因的区域,所述区域含有一致的单核苷酸 疫苗与MDV-1毒株之间的多态性(SNP)差异; 和(b)使(a)的扩增的核酸与对MDV-1的疫苗株的SNP特异性的可检测的核酸探针和/或对于毒性毒株的SNP特异性的可检测的核酸探针接触 MDV-1; 和(iii)测量由(ii)的探针产生的可检测信号的变化。 还提供了用于绝对定量疫苗和毒性病毒的方法。
-
公开(公告)号:US20060269910A1
公开(公告)日:2006-11-30
申请号:US10530073
申请日:2003-10-14
申请人: Venugopal Nair , Susan Baigent , Richard Currie
发明人: Venugopal Nair , Susan Baigent , Richard Currie
CPC分类号: C12Q1/6806 , C12Q1/701
摘要: The invention relates to methods of detecting a virus in an avian tissue sample wherein genetic material derived from feathers is tested for the presence of genetic material from the virus.
-
公开(公告)号:US08865409B2
公开(公告)日:2014-10-21
申请号:US13391563
申请日:2010-08-25
申请人: Susan Baigent , Venugopal Nair , Hervé Le Galludec
发明人: Susan Baigent , Venugopal Nair , Hervé Le Galludec
CPC分类号: C12Q1/705 , C12Q2600/156
摘要: A method for the quantification of a vaccine strain and/or a virulent strain of Marek's Disease Virus Serotype-1 (MDV-1) in a sample from a bird, comprising the steps of: (i) providing a biological sample from the bird and optionally isolating nucleic acid from the biological sample; (ii) subjecting the biological sample of (i) to real-time quantitative PCR (qPCR) comprising: (a) amplification of a region of the pp38 gene within the nucleic acid sample of (i), said region containing a consistent single nucleotide polymorphism (SNP) difference between vaccine and virulent strains of MDV-1; and (b) contacting the amplified nucleic acid of (a) with a detectable nucleic acid probe specific for the SNP of the vaccine strain of MDV-1 and/or a detectable nucleic acid probe specific for the SNP of the virulent strain of MDV-1; and (iii) Measuring changes in the detectable signal produced by the probe of (ii). Methods are also provided for the absolute quantification of vaccine and virulent viruses.
摘要翻译: 一种用于在来自鸟的样品中定量疫苗株和/或马立克氏病病毒血清型1(MDV-1)的毒性菌株的方法,包括以下步骤:(i)从鸟提供生物样品, 任选地从生物样品中分离核酸; (ii)对(i)的生物样品进行实时定量PCR(qPCR),包括:(a)在(i)的核酸样品中扩增pp38基因的区域,所述区域含有一致的单核苷酸 疫苗与MDV-1毒株之间的多态性(SNP)差异; 和(b)使(a)的扩增的核酸与对MDV-1的疫苗株的SNP特异的可检测的核酸探针和/或特异于MDV-1的毒力株的SNP的可检测的核酸探针接触, 1; 和(iii)测量由(ii)的探针产生的可检测信号的变化。 还提供了用于绝对定量疫苗和毒性病毒的方法。
-
公开(公告)号:US20120076823A1
公开(公告)日:2012-03-29
申请号:US12997844
申请日:2009-06-11
申请人: Venugopal Nair , Luke Lambeth
发明人: Venugopal Nair , Luke Lambeth
IPC分类号: A61K39/245 , A61K31/7088 , A61P37/04 , A61P35/00 , A61P37/08 , A61P25/00 , A61P9/12 , C12N15/869 , A61P31/00
CPC分类号: C12N15/111 , C12N2310/111 , C12N2310/14 , C12N2310/141 , C12N2320/50 , C12N2710/16043
摘要: The present invention relates to a herpes virus vector which comprises a modified genomic sequence encoding a microRNA (miRNA) against a target sequence. The herpes virus vector may be used as or in a vaccine to prevent and/or treat a disease.
摘要翻译: 本发明涉及一种疱疹病毒载体,其包含编码针对靶序列的微小RNA(miRNA)的修饰基因组序列。 疱疹病毒载体可以用作疫苗或在疫苗中用于预防和/或治疗疾病。
-
公开(公告)号:US08501466B2
公开(公告)日:2013-08-06
申请号:US12997844
申请日:2009-06-11
申请人: Venugopal Nair , Luke Lambeth
发明人: Venugopal Nair , Luke Lambeth
CPC分类号: C12N15/111 , C12N2310/111 , C12N2310/14 , C12N2310/141 , C12N2320/50 , C12N2710/16043
摘要: The present invention relates to a herpes virus vector which comprises a modified genomic sequence encoding a microRNA (miRNA) against a target sequence. The herpes virus vector may be used as or in a vaccine to prevent and/or treat a disease.
摘要翻译: 本发明涉及一种疱疹病毒载体,其包含编码针对靶序列的微小RNA(miRNA)的修饰基因组序列。 疱疹病毒载体可以用作疫苗或在疫苗中用于预防和/或治疗疾病。
-
-
-
-